Borosil Scientific quarterly results

Q2 FY27 · Jul–Sep 2026

₹ crore	Q2 FY27	Q2 FY26	Change
Revenue	115	107	+7.5%
EBITDA	10.7	8.0	+33.4%
EBITDA margin	9.3%	7.5%	+1.8 pts
Profit before tax	7.7	5.1	+49.4%
Net profit	5.3	2.8	+86.4%
EPS	₹0.60	₹0.32	+87.5%

Every quarter

₹ crore except per share

Tap a line for its trend	Q2 FY27Sep 2026	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024

Expenses
	115	107	143	121	107	96.0	129	101	103	104
	2.4	2.7	2.1	2.4	2.1	2.9	2.6	1.9	1.9	2.2
	117	109	145	124	109	98.9	132	103	105	106
	43.2	41.0	44.5	41.2	39.2	33.6	41.1	34.9	33.4	34.1
	0.6	0.4	3.0	3.8	2.4	2.1	5.4	2.8	3.5	2.1
	−4.4	−8.1	2.6	−1.5	−2.9	−1.1	5.5	−0.0	−2.4	1.1
	21.9	22.0	17.9	21.6	20.6	20.1	19.8	19.5	18.6	19.2
	0.2	0.3	0.3	0.3	0.2	0.4	0.4	0.4	0.4	0.4
	5.2	4.9	4.8	4.8	4.8	4.9	4.7	4.6	4.6	4.6
	42.9	43.0	43.1	39.0	39.6	36.5	41.0	34.4	34.1	37.8
	110	103	116	109	104	96.4	118	96.4	92.2	99.3
	10.7	8.5	32.1	17.2	8.0	4.9	16.6	10.0	15.4	9.8
	5.5	3.6	27.3	12.4	3.2	−0.0	11.9	5.4	10.8	5.3
Profit
	7.7	6.0	29.1	14.6	5.1	2.5	14.0	6.9	12.4	7.0
	0.0	0.0	0.0	−1.9	0.0	−6.6	0.0	0.0	0.0	0.0
	7.7	6.0	29.1	12.6	5.1	−4.1	14.0	6.9	12.4	7.0
	2.9	1.8	7.4	3.9	3.1	0.0	3.9	2.4	3.2	1.3
	−0.6	−0.1	−5.5	−0.0	−0.8	0.1	1.5	0.2	0.4	0.7
	2.4	1.6	1.9	3.9	2.3	0.1	5.4	2.7	3.6	2.0
	5.3	4.4	27.2	8.7	2.8	−4.2	8.6	4.3	8.8	5.0
	5.3	4.4	27.2	8.7	2.8	−4.2	8.6	4.3	8.8	5.0
	−0.1	−0.1	−0.0	0.0	−0.0	−0.0	−0.1	−0.0	−0.0	−0.0
	5.3	4.3	27.2	8.7	2.8	−4.2	8.5	4.2	8.8	5.0
	5.3	4.4	27.2	8.7	2.9	−4.2	8.7	4.3	8.8	5.0
	−0.0	−0.0	0.0	0.0	−0.0	−0.0	−0.1	−0.0	0.0	−0.0
Per share
	₹0.60	₹0.49	₹3.06	₹0.98	₹0.32	−₹0.47	₹0.98	₹0.48	₹0.99	₹0.57
	₹0.60	₹0.49	₹3.06	₹0.98	₹0.32	−₹0.47	₹0.98	₹0.48	₹0.99	₹0.57
Other comprehensive income — detail
	−0.1	−0.1	−0.0	0.0	−0.0	−0.0	−0.1	—	—	—
	−0.1	−0.1	−0.0	0.0	−0.0	−0.0	−0.1	−0.1	−0.1	−0.1
	−0.0	−0.0	−0.0	0.0	−0.0	−0.0	−0.0	—	—	—
	—	—	—	—	—	—	—	−0.0	−0.0	−0.0
	5.3	4.3	27.2	8.7	2.9	−4.2	8.6	4.3	8.7	5.0
	−0.0	−0.0	0.0	0.0	−0.0	−0.0	−0.1	−0.0	0.0	−0.0
Per share — as-filed variants
	₹0.60	₹0.49	₹3.06	₹0.98	₹0.32	−₹0.47	₹0.98	₹0.48	₹0.99	₹0.57
	₹0.60	₹0.49	₹3.06	₹0.98	₹0.32	−₹0.47	₹0.98	₹0.48	₹0.99	₹0.57
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	75.5	73.4	93.1	77.7	68.2	61.4	77.4	63.8	68.1	66.9
	65.7%	68.8%	65.1%	64.1%	63.8%	64.0%	59.8%	62.9%	66.4%	64.2%
Adjusted (ex-exceptional items) — derived
	7.7	6.0	29.1	14.6	5.1	2.5	14.0	6.9	12.4	7.0
	0.0	0.0	0.0	−1.9	0.0	−6.6	0.0	0.0	0.0	0.0
	5.3	4.4	27.2	10.0	2.8	2.4	8.6	4.3	8.8	5.0
	₹0.60	₹0.49	₹3.06	₹1.13	₹0.32	₹0.27	₹0.98	₹0.48	₹0.99	₹0.57

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

BOROSCI₹103.27

Borosil Scientific Limited

· Capital Goods & Defence

Annual Quarterly₹ CrorePeersSEJALLTDMcap ₹919 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Revenue from Operations	104.2	102.6	101.5	129.5	96.0	106.9	121.3	143.2	106.8	115.0
Other Income	2.2	1.9	1.9	2.6	2.9	2.1	2.4	2.1	2.7	2.4
Total Income	106.4	104.6	103.3	132.1	98.9	109.0	123.7	145.2	109.4	117.4
Expenses
+ Cost of Materials Consumed	34.1	33.4	34.9	41.1	33.6	39.2	41.2	44.5	41.0	43.2
+ Purchases of Stock-in-Trade	2.1	3.5	2.8	5.4	2.1	2.4	3.8	3.0	0.4	0.6
+ Changes in Inventories	1.1	-2.4	-0.0	5.5	-1.1	-2.9	-1.5	2.6	-8.1	-4.4
+ Employee Benefit Expense	19.2	18.6	19.5	19.8	20.1	20.6	21.6	17.9	22.0	21.9
+ Finance Costs	0.4	0.4	0.4	0.4	0.4	0.2	0.3	0.3	0.3	0.2
+ Depreciation & Amortisation	4.6	4.6	4.6	4.7	4.9	4.8	4.8	4.8	4.9	5.2
+ Other Expenses	37.8	34.1	34.4	41.0	36.5	39.6	39.0	43.1	43.0	42.9
Total Expenses	99.3	92.2	96.4	118.1	96.4	103.9	109.2	116.1	103.4	109.7
EBITDA	9.8	15.4	10.0	16.6	4.9	8.0	17.2	32.1	8.5	10.7
EBIT	5.3	10.8	5.4	11.9	-0.0	3.2	12.4	27.3	3.6	5.5
Profit
PBT before Exceptional Items	7.0	12.4	6.9	14.0	2.5	5.1	14.6	29.1	6.0	7.7
+ Exceptional Items	0.0	0.0	0.0	0.0	-6.6	0.0	-1.9	0.0	0.0	0.0
Pretax Income	7.0	12.4	6.9	14.0	-4.1	5.1	12.6	29.1	6.0	7.7
+ Current Tax	1.3	3.2	2.4	3.9	0.0	3.1	3.9	7.4	1.8	2.9
+ Deferred Tax	0.7	0.4	0.2	1.5	0.1	-0.8	-0.0	-5.5	-0.1	-0.6
Tax Expense	2.0	3.6	2.7	5.4	0.1	2.3	3.9	1.9	1.6	2.4
Net Income	5.0	8.8	4.3	8.6	-4.2	2.8	8.7	27.2	4.4	5.3
+ Net Income — Continuing Ops	5.0	8.8	4.3	8.6	-4.2	2.8	8.7	27.2	4.4	5.3
+ Other Comprehensive Income	-0.0	-0.0	-0.0	-0.1	-0.0	-0.0	0.0	-0.0	-0.1	-0.1
Total Comprehensive Income	5.0	8.8	4.2	8.5	-4.2	2.8	8.7	27.2	4.3	5.3
Net Income to Common	5.0	8.8	4.3	8.7	-4.2	2.9	8.7	27.2	4.4	5.3
Minority Interest	-0.0	0.0	-0.0	-0.1	-0.0	-0.0	0.0	0.0	-0.0	-0.0
Per Share
Basic EPS	0.57	0.99	0.48	0.98	-0.47	0.32	0.98	3.06	0.49	0.60
Diluted EPS	0.57	0.99	0.48	0.98	-0.47	0.32	0.98	3.06	0.49	0.60
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	-0.1	-0.0	-0.0	0.0	-0.0	-0.1	-0.1
+ Items NOT to be Reclassified to P&L	-0.1	-0.1	-0.1	-0.1	-0.0	-0.0	0.0	-0.0	-0.1	-0.1
+ Tax on Items NOT to be Reclassified	—	—	—	-0.0	-0.0	-0.0	0.0	-0.0	-0.0	-0.0
+ Tax on Items NOT to be Reclassified — alt tag	-0.0	-0.0	-0.0	—	—	—	—	—	—	—
Comprehensive Income — Owners of Parent	5.0	8.7	4.3	8.6	-4.2	2.9	8.7	27.2	4.3	5.3
Comprehensive Income — Non-controlling Interests	-0.0	0.0	-0.0	-0.1	-0.0	-0.0	0.0	0.0	-0.0	-0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations	0.57	0.99	0.48	0.98	-0.47	0.32	0.98	3.06	0.49	0.60
Diluted EPS — Continuing Operations	0.57	0.99	0.48	0.98	-0.47	0.32	0.98	3.06	0.49	0.60
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	66.9	68.1	63.8	77.4	61.4	68.2	77.7	93.1	73.4	75.5
Gross Margin %	64.20	66.39	62.91	59.78	63.99	63.83	64.07	65.06	68.79	65.69
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	7.0	12.4	6.9	14.0	2.5	5.1	14.6	29.1	6.0	7.7
− Exceptional Items (reconciliation)	0.0	0.0	0.0	0.0	-6.6	0.0	-1.9	0.0	0.0	0.0
Net Income Adj (tax-effected)	5.0	8.8	4.3	8.6	2.4	2.8	10.0	27.2	4.4	5.3
EPS Adj	0.57	0.99	0.48	0.98	0.27	0.32	1.13	3.06	0.49	0.60
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Paid Up Equity Capital	8.9	8.9	8.9	8.9	8.9	8.9	8.9	8.9	8.9	8.9

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q2 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Borosil Scientific Q2 FY27 results (July–September 2026)

Filed with NSE on Wednesday, 28 October 2026 at 6:11 pm IST

Borosil Scientific (NSE: BOROSCI) reported its Q2 FY27 results (July–September 2026) on Wednesday, 28 October 2026 at 6:11 pm IST. Consolidated net profit was ₹5.3 crore, up 83.7% from ₹2.9 crore in Q2 FY26 and up 21.5% from ₹4.4 crore in Q1 FY27. Revenue from operations was ₹115 crore, up 7.5% year on year and up 7.7% from the previous quarter.

Q2 FY26 results (a year earlier): 6 November 2025
Q3 FY27 results due by: 14 February 2027

Q2 FY27 at a glance · consolidated

Net profit: ₹5.3 Cr+83.7% vs Q2 FY26+21.5% vs Q1 FY27
Revenue from operations: ₹115 Cr+7.5% vs Q2 FY26+7.7% vs Q1 FY27
Operating margin (EBIT): 4.8%+1.8 pts vs Q2 FY26+1.4 pts vs Q1 FY27EBIT ₹5.5 Cr
EBITDA: ₹10.7 Cr+33.4% vs Q2 FY26+26.6% vs Q1 FY27margin 9.3%
Earnings per share (basic): ₹0.60+87.5% vs Q2 FY26+22.4% vs Q1 FY27
Net profit margin: 4.6%+1.9 pts vs Q2 FY26+0.5 pts vs Q1 FY27

Questions

What was Borosil Scientific's net profit in Q2 FY27?

Consolidated net profit was ₹5.3 crore, up 83.7% from ₹2.9 crore in Q2 FY26 and up 21.5% from ₹4.4 crore in Q1 FY27.

What was Borosil Scientific's revenue in Q2 FY27?

Revenue from operations was ₹115 crore, up 7.5% year on year and up 7.7% from the previous quarter.

How were Borosil Scientific's Q2 FY27 results?

Both grew from a year earlier: net profit was up 83.7% at ₹5.3 crore and revenue was up 7.5% at ₹115 crore. The operating margin was 4.8%, up 1.8 percentage points from 3.0% a year earlier. Against Q1 FY27, net profit was up 21.5% and revenue up 7.7%.

What was Borosil Scientific's operating margin in Q2 FY27?

Operating profit (EBIT — revenue less operating expenses, before finance costs and other income) was ₹5.5 crore, a margin of 4.8%, against 3.3% in Q1 FY27 and 3.0% in Q2 FY26. EBITDA was ₹10.7 crore, 9.3% of revenue.

What was Borosil Scientific's net profit in the first half of FY27?

Consolidated net profit for the first half of FY27 (April–September 2026) was ₹9.7 crore, against a loss of ₹1.3 crore in the same months a year earlier. Revenue from operations was ₹222 crore, up 9.3%.

What is Borosil Scientific's net profit margin?

Borosil Scientific's net profit margin was 4.6% in Q2 FY27 (net profit as a share of revenue from operations), against 2.7% in Q2 FY26 (up 1.9 percentage points). For FY26 as a whole it was 7.4%.

What was Borosil Scientific's EPS in Q2 FY27?

Basic earnings per share were ₹0.60, against ₹0.32 in Q2 FY26.

What was Borosil Scientific's net profit in FY26?

Consolidated net profit was ₹34.6 crore in FY26 (April 2025–March 2026), up 29.1% from ₹26.8 crore in FY25.

What was Borosil Scientific's revenue in FY26?

Revenue from operations was ₹467 crore in FY26 (April 2025–March 2026), up 6.6% from ₹438 crore in FY25.

How has Borosil Scientific's profit changed over the last four quarters?

Net profit by quarter: ₹8.7 crore in Q3 FY26, ₹27.2 crore in Q4 FY26, ₹4.4 crore in Q1 FY27 and ₹5.3 crore in Q2 FY27. That is ₹45.6 crore over the four quarters, up 289.4% from ₹11.7 crore in the four quarters before. Revenue from operations: ₹121 crore, ₹143 crore, ₹107 crore and ₹115 crore.

When did Borosil Scientific announce its Q2 FY27 results?

On Wednesday, 28 October 2026 at 6:11 pm IST, in its results filing to the stock exchanges. A year earlier it reported Q2 FY26 on 6 November 2025.

When will Borosil Scientific announce its Q3 FY27 results?

Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.

Where do these Borosil Scientific figures come from?

From Borosil Scientific's own consolidated results filings to NSE, in ₹ crore as filed (Q2 FY27 on 28 October 2026). Growth compares the same consolidated figures a year and a quarter earlier.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.